Mentice

About Mentice

In 1998, Mentice was founded in Gothenburg, Sweden, marking the beginning of a new era in medical simulation. The company was established by a team of innovators dedicated to improving clinical outcomes through advanced simulation technology. While specific founders' names are not prominently highlighted, the company's mission was clear from the start: to enhance the training of healthcare professionals using cutting-edge simulation solutions.

Mentice quickly became a leader in providing software and hardware simulation solutions for image-guided interventional therapies. Their technology allowed medical professionals to practice and refine their skills in a risk-free environment, ultimately improving patient care and safety.

In 2019, Mentice reached a significant milestone by going public on the Stockholm Stock Exchange's First North Growth Market. This IPO was a pivotal moment, providing the company with the capital needed to expand its offerings and reach a broader audience.

Throughout its journey, Mentice has continued to grow and innovate. In 2022, the company acquired the Ankyras product line from Galgo Medical, further solidifying its position as a comprehensive provider of medical simulation solutions. This acquisition was a strategic move to enhance their product portfolio and offer a more integrated solution to their clients.

Today, Mentice stands as a testament to the power of innovation in healthcare, continually pushing the boundaries of what's possible in medical training and simulation. Their journey reflects a commitment to improving healthcare outcomes through technology, making a lasting impact on the industry.